Drug-eluting bead transarterial chemoembolization combined with immune checkpoint inhibitors is associated with improved progression-free survival in locally advanced or metastatic sarcoma: a retrospective propensity score-matched analysis
Therapeutic Advances in Medical Oncology
Published online on May 25, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Immune checkpoint inhibitors (ICIs) have shown limited efficacy in unselected advanced sarcomas. Drug-eluting bead transarterial chemoembolization (dTACE) may enhance antitumor immunity through localized chemotherapy and immunogenic cell death....
Background:Immune checkpoint inhibitors (ICIs) have shown limited efficacy in unselected advanced sarcomas. Drug-eluting bead transarterial chemoembolization (dTACE) may enhance antitumor immunity through localized chemotherapy and immunogenic cell death....